These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11757572)

  • 1. Requirements for facilities transferring or receiving select agents. Final rule.
    Center for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS)
    Fed Regist; 2001 Aug; 66(170):45944-5. PubMed ID: 11757572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site registration fee schedule and related matters for facilities transferring or receiving select agents--CDC. Notice.
    Fed Regist; 1997 Apr; 62(71):18134-5. PubMed ID: 10167222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical laboratories, the select agent program, and biological surety (biosurety).
    Pastel RH; Demmin G; Severson G; Torres-Cruz R; Trevino J; Kelly J; Arrison J; Christman J
    Clin Lab Med; 2006 Jun; 26(2):299-312, vii. PubMed ID: 16815454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A primer on the requirements for select agents and toxins used in biomedical and agricultural research applications.
    Johnston TP
    Health Phys; 2006 May; 90(5 Suppl):S56-61. PubMed ID: 16607169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDC recommendations for civilian communities near chemical weapons depots: guidelines for medical preparedness--CDC. Publication of final recommendations.
    Fed Regist; 1995 Jun; 60(123):33308-12. PubMed ID: 10143398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Select agents. Researchers relieved by final biosecurity rules.
    Kaiser J
    Science; 2005 Apr; 308(5718):31. PubMed ID: 15802570
    [No Abstract]   [Full Text] [Related]  

  • 7. Review of Restricted Experiment Requests, Division of Select Agents and Toxins, Centers for Disease Control and Prevention, 2006-2013.
    Smith J; Gangadharan D; Weyant R
    Health Secur; 2015; 13(5):307-16. PubMed ID: 26347984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosafety: guidelines for working with pathogenic and infectious microorganisms.
    Coico R; Lunn G
    Curr Protoc Microbiol; 2005 Jul; Chapter 1A():Unit 1A.1. PubMed ID: 18770561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possession, use, and transfer of select agents and toxins. Final rule.
    Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS)
    Fed Regist; 2008 Oct; 73(201):61363-6. PubMed ID: 19024787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possession, use, and transfer of select agents and toxins. Final rule.
    Centers for Disease Control and Prevention, Office of Inspector General, Department of Health and Human Services (HHS)
    Fed Regist; 2005 Mar; 70(52):13293-325. PubMed ID: 15776528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revision of the requirements for live vaccine processing. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Oct; 72(201):59000-3. PubMed ID: 17966559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Dec; 72(232):68064-70. PubMed ID: 18064770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory security and emergency response guidance for laboratories working with select agents. Centers for Disease Control and Prevention.
    Richmond JY; Nesby-O'Dell SL
    MMWR Recomm Rep; 2002 Dec; 51(RR-19):1-6. PubMed ID: 12515340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious substances--DOT. Final rule.
    Fed Regist; 1995 Sep; 60(182):48780-7. PubMed ID: 10151186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review of the List of Select Agents and Toxins and Enhanced Biosafety Requirements. Final rule.
    Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS)
    Fed Regist; 2017 Jan; 82(12):6278-94. PubMed ID: 28106357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisions to the requirements applicable to blood, blood components and source plasma. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(158):45883-88. PubMed ID: 17847577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel.
    Miller JM; Astles R; Baszler T; Chapin K; Carey R; Garcia L; Gray L; Larone D; Pentella M; Pollock A; Shapiro DS; Weirich E; Wiedbrauk D; ;
    MMWR Suppl; 2012 Jan; 61(1):1-102. PubMed ID: 22217667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance-oriented packaging standards; revisions to transitional provisions--Department of Transportation. Final rule; partial response to petitions for reconsideration and revisions.
    Fed Regist; 1991 Sep; 56(181):47158-63. PubMed ID: 10114364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of communicable diseases; apprehension and detention of persons with specific diseases; transfer of regulations. Food and Drug Administration and Centers for Disease Control and Prevention, HHS. Final rule.
    Fed Regist; 2000 Aug; 65(159):49906-9. PubMed ID: 11067729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Draft Guidelines for Preventing the Transmission of Tuberculosis in Health-Care Facilities, Second Edition; notice of comment period--CDC, PHS, DHHS. Notice.
    Fed Regist; 1993 Oct; 58(195):52810-54. PubMed ID: 10130530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.